- Report
- February 2025
- 85 Pages
India
From €3194EUR$3,500USD£2,714GBP
- Report
- October 2024
- 87 Pages
Spain
From €3194EUR$3,500USD£2,714GBP
- Report
- September 2024
- 82 Pages
Japan
From €3194EUR$3,500USD£2,714GBP
- Report
- August 2024
- 85 Pages
India
From €3194EUR$3,500USD£2,714GBP
- Report
- August 2024
- 82 Pages
Japan
From €3194EUR$3,500USD£2,714GBP
- Report
- February 2024
- 184 Pages
Global
From €4106EUR$4,500USD£3,489GBP
- Report
- February 2024
- 170 Pages
Global
From €4106EUR$4,500USD£3,489GBP
- Report
- February 2024
- 172 Pages
Global
From €4106EUR$4,500USD£3,489GBP
- Report
- November 2023
- 171 Pages
Global
From €4106EUR$4,500USD£3,489GBP
- Report
- November 2023
- 90 Pages
France
From €3194EUR$3,500USD£2,714GBP
- Report
- October 2023
- 186 Pages
Global
From €4106EUR$4,500USD£3,489GBP
- Report
- October 2023
- 81 Pages
Japan
From €3194EUR$3,500USD£2,714GBP
- Report
- October 2023
- 190 Pages
Global
From €4106EUR$4,500USD£3,489GBP
- Report
- July 2023
- 78 Pages
United States
From €3194EUR$3,500USD£2,714GBP
- Report
- March 2023
- 117 Pages
Global
From €4106EUR$4,500USD£3,489GBP
- Report
- December 2022
- 111 Pages
Global
From €4106EUR$4,500USD£3,489GBP
- Report
- February 2024
- 70 Pages
Europe
From €4334EUR$4,750USD£3,683GBP
- Report
- April 2023
- 111 Pages
Global
From €4334EUR$4,750USD£3,683GBP
- Report
- April 2023
- 110 Pages
Global
From €4334EUR$4,750USD£3,683GBP
- Report
- October 2022
- 113 Pages
Global
From €4334EUR$4,750USD£3,683GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more